On Monday, Anthropic announced Claude 3.7 Sonnet, a new AI language model with a simulated reasoning (SR) capability called " ...
On-demand video webcast now available here PRINCETON, N.J., March 11, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the “Company” or “Sonnet”) (NASDAQ: SONN), a clinical-stage ...
Based on results across various benchmarks, Claude 3.7 Sonnet is back in the lead in the white-hot race for AI supremacy, ...
Inc. (the “Company” or “Sonnet”) (NASDAQ: SONN), a clinical-stage company developing targeted immunotherapeutic drugs, today announced it participated in the Virtual Investor "Top 5 for ...
Sonnet BioTherapeutics Holdings, Inc. recently participated in the Virtual Investor "Top 5 for ‘25” On-Demand Conference, where CEO Pankaj Mohan, Ph.D., outlined five reasons for the ...
However, these tools face an incoming threat from Anthropic. Along with the 3.7 Sonnet, the company also launched an ‘agentic’ coding tool called Claude Code. This tool functions as an active ...
Explore key differences, creative applications, and whether the price increase is justified for your needs. Uncover GPT-4.5 ...